Blue Water Capital Markets initiates coverage on AngioDynamics (Nasdaq: ANGO) with a 'Buy' rating and $19 price target.

The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE